<?xml version="1.0" encoding="UTF-8"?>
<PAPER>

<BODY>
<DIV><P>
</P>
<P>[0001] AN IMPROVED PROCESS FOR PREPARING <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.26" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">TAMSULOSIN</ne>
HYDROCHLORIDE
FIELD OF THE INVENTION
The invention relates to an improved process for preparing the <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.157" epochem-id="EPOCHEM:NEW:COMPOUND:1795" name="(/?)-(-)- 5-[2- [[2-(2- ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide monohydrochloride" comment="(R)-(-)- 5-[2- [[2-(2- ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide monohydrochloride" chebi-id="WO2007031823:59609" relevant="true">(/?)-(-)- 5-[2- [[2-(2- ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide monohydrochloride</ne> of Formula I.
Formula I
</P>
<P>[0006]
EMI2.1
BACKGROUND OF THE INVENTION
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.152" epochem-id="EPOCHEM:NEW:COMPOUND:1794" name="(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide" comment="(R)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:642699" relevant="true">(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide</ne> is known as <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.27" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>. Presently <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.28" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> is being marketed as its <ne id="WO2007031823.HC.class-names.19" epochem-id="EPOCHEM:NEW:CLASS:952" name="hydrochloride salt" comment="" chebi-id="WO2007031823:710264" relevant="false" type="CLASS">hydrochloride salt</ne> under the Trade name <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.195" epochem-id="EPOCHEM:NEW:COMPOUND:2017" name="FLOMAX" comment="" chebi-id="CHEBI:9399" relevant="false">FLOMAX</ne>. It is an [alpha]-adrenergic antagonist used preferably for treating benign prostatic hyperplasia.
US 4,703,063 describes two processes for the preparation of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.29" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>, one of which involves the conversion of a <ne type="LIGAND" id="WO2007031823.HC.ligand-names.64" epochem-id="EPOCHEM:NEW:LIGAND:540" name="hydroxy" comment="" chebi-id="CHEBI:43176" relevant="false">hydroxy</ne> substituted analogue of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.30" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>, i.e., a compound having the <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.31" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> structure but contains a <ne type="LIGAND" id="WO2007031823.HC.ligand-names.37" epochem-id="EPOCHEM:NEW:LIGAND:1" name="hydroxyl" comment="" chebi-id="CHEBI:29191" relevant="false">hydroxyl</ne> substituent at a position [alpha] to the <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.158" epochem-id="EPOCHEM:NEW:COMPOUND:1796" name="benzenesulfonamide" comment="" chebi-id="WO2007031823:7428" relevant="false">benzenesulfonamide</ne> ring, by halogenation followed by reduction and the other involves condensation of an appropriately substituted <ne id="WO2007031823.HC.class-names.16" epochem-id="EPOCHEM:NEW:CLASS:647" name="benzyl methyl ketone" comment="" chebi-id="WO2007031823:324963" relevant="false" type="CLASS">benzyl methyl ketone</ne> with the substituted <ne id="WO2007031823.HC.class-names.15" epochem-id="EPOCHEM:NEW:CLASS:646" name="phenoxy amine" comment="" chebi-id="WO2007031823:773395" relevant="false" type="CLASS">phenoxy amine</ne>, followed by reduction of the resulting imino compound. The above described processes are rion-stereospecif[iota]c and the final product requires an additional step of resolution of enantiomers to specifically obtain (i?)-enantiomer <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.32" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">tamsulosin</ne>.
CA 1,282,077 discloses a process to prepare <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.33" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> wherein (i?)-enantiomer of <ne id="WO2007031823.HC.class-names.14" epochem-id="EPOCHEM:NEW:CLASS:645" name="sulfonamide amine" comment="" chebi-id="WO2007031823:490158" relevant="false" type="CLASS">sulfonamide amine</ne> has been condensed with <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.151" epochem-id="EPOCHEM:NEW:COMPOUND:1793" name="ethoxy phenoxy bromide" comment="" chebi-id="WO2007031823:66056" relevant="false">ethoxy phenoxy bromide</ne> in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.150" epochem-id="EPOCHEM:NEW:COMPOUND:334" name="dimethylformamide" comment="" chebi-id="CHEBI:17741" relevant="false">dimethylformamide</ne> to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.34" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> {Scheme I), which was purified by crystallization before converting into <ne id="WO2007031823.HC.class-names.20" epochem-id="EPOCHEM:NEW:CLASS:952" name="hydrochloride salt" comment="" chebi-id="WO2007031823:710264" relevant="false" type="CLASS">hydrochloride salt</ne>.
</P>
<P>[0011]
EMI3.1
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.149" epochem-id="EPOCHEM:NEW:COMPOUND:1792" name="0R)-(-)-SULFONAMIDE AMINE 2-(2-ETHOXYPHENOXY)ETHYL BROMIDE TAMSULOSIN" comment="(R)-(-)-SULFONAMIDE AMINE 2-(2-ETHOXYPHENOXY)ETHYL BROMIDE TAMSULOSIN" chebi-id="WO2007031823:664775" relevant="false">0R)-(-)-SULFONAMIDE AMINE 2-(2-ETHOXYPHENOXY)ETHYL BROMIDE TAMSULOSIN</ne>
(i) Recrystallization from IPA (ii) <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.84" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">Methanol</ne> /<ne type="FORMULA" id="WO2007031823.HC.formula-names.2" epochem-id="EPOCHEM:NEW:FORMULA:48" name="HCI" comment="HCl" chebi-id="WO2007031823:199253" relevant="false">HCI</ne>
</P>
<P>[0014]
EMI3.2
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.1" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne>
Scheme I
As per the above described process, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.2" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> is obtained in low yield, and therefore this process is not suitable for commercial production.
WO 2002/068382 Al discloses a process to prepare <ne type="LIGAND" id="WO2007031823.HC.ligand-names.38" epochem-id="EPOCHEM:NEW:LIGAND:538" name="sulfamoyl" comment="" chebi-id="CHEBI:48266" relevant="false">sulfamoyl</ne> substituted phenethylamine derivatives including <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.38" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>. The described process involves a coupling reaction between <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.21" epochem-id="EPOCHEM:NEW:COMPOUND:1782" name="(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" comment="R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:512503" relevant="false">(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide</ne> with an <ne id="WO2007031823.HC.class-names.26" epochem-id="EPOCHEM:NEW:CLASS:1073" name="acid" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acid</ne> or a corresponding <ne id="WO2007031823.HC.class-names.24" epochem-id="EPOCHEM:NEW:CLASS:1141" name="acid chloride" comment="" chebi-id="WO2007031823:226790" relevant="false" type="CLASS">acid chloride</ne> or mixed <ne id="WO2007031823.HC.class-names.32" epochem-id="EPOCHEM:NEW:CLASS:136" name="anhydride" comment="" chebi-id="WO2007031823:872489" relevant="false" type="CLASS">anhydride</ne> to produce <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.196" epochem-id="EPOCHEM:NEW:COMPOUND:2132" name="Tamsulosin amide" comment="" chebi-id="WO2007031823:143947" relevant="false">Tamsulosin amide</ne> and thereafter reduction of the obtained compound gives <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.40" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>. This coupling reaction presents the disadvantage that the <ne id="WO2007031823.HC.class-names.28" epochem-id="EPOCHEM:NEW:CLASS:1073" name="acid" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acid</ne> or <ne id="WO2007031823.HC.class-names.25" epochem-id="EPOCHEM:NEW:CLASS:1141" name="acid chloride" comment="" chebi-id="WO2007031823:226790" relevant="false" type="CLASS">acid chloride</ne> or <ne id="WO2007031823.HC.class-names.33" epochem-id="EPOCHEM:NEW:CLASS:136" name="anhydride" comment="" chebi-id="WO2007031823:872489" relevant="false" type="CLASS">anhydride</ne> should be provided in a high purity in order to obtain a good yield in the coupling reaction; and it is known in the art that purification of such products is not always easy.
WO 2004/022532 Al discloses a process to prepare <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.41" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> {Scheme II) wherein protected amine is used during condensation with <ne type="LIGAND" id="WO2007031823.HC.ligand-names.63" epochem-id="EPOCHEM:NEW:LIGAND:4" name="ethoxy" comment="" chebi-id="CHEBI:42241" relevant="false">ethoxy</ne> <ne type="LIGAND" id="WO2007031823.HC.ligand-names.60" epochem-id="EPOCHEM:NEW:LIGAND:539" name="phenoxy" comment="" chebi-id="WO2007031823:634678" relevant="false">phenoxy</ne> derivative to obtain protected <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.42" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>. In this process, an additional step of removing the protecting group to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.43" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> is involved.
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.145" epochem-id="EPOCHEM:NEW:COMPOUND:859" name="Xylene" comment="" chebi-id="CHEBI:27338" relevant="false">Xylene</ne>
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.144" epochem-id="EPOCHEM:NEW:COMPOUND:1790" name="2-(2-eth oxy ph en oxy) ethyl" comment="" chebi-id="WO2007031823:205908" relevant="false">2-(2-eth oxy ph en oxy) ethyl</ne>
EMI4.2
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.146" epochem-id="EPOCHEM:NEW:COMPOUND:1791" name="methanesulfonate" comment="" chebi-id="CHEBI:25224" relevant="false">methanesulfonate</ne> <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.79" epochem-id="EPOCHEM:NEW:COMPOUND:1784" name="magnesium oxide" comment="" chebi-id="CHEBI:31794" relevant="false">Magnesium oxide</ne>
EMI4.1
<ne type="FORMULA" id="WO2007031823.HC.formula-names.1" epochem-id="EPOCHEM:NEW:FORMULA:141" name="Pd" comment="" chebi-id="CHEBI:33363" relevant="false">Pd</ne> / C / Hydrogen
</P>
<P>[0023]
EMI4.3
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.44" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">TAMSULOSIN</ne>
Scheme II
This process involves the use of a protected amine derivative, which needs to be deprotected after the formation of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.45" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>.
EP 0 380 144 Bl describes a process for preparing <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.46" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> and the like, in stereospecific form, by reaction of a <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.159" epochem-id="EPOCHEM:NEW:COMPOUND:1796" name="benzenesulfonamide" comment="" chebi-id="WO2007031823:7428" relevant="false">benzenesulfonamide</ne> amine with predetermined stereospecificity, with <ne id="WO2007031823.HC.class-names.12" epochem-id="EPOCHEM:NEW:CLASS:643" name="2-(2-ethoxyphenoxy)ethyl halide" comment="" chebi-id="WO2007031823:313552" relevant="false" type="CLASS">2-(2-ethoxyphenoxy)ethyl halide</ne>, specifically the bromide. In this process, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.47" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> base has been purified with column chromatography. WO 2004/016582 discloses a process to prepare <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.3" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> {Scheme III). This process involves two additional steps, first the protection of amine group before condensing with <ne id="WO2007031823.HC.class-names.13" epochem-id="EPOCHEM:NEW:CLASS:644" name="ethoxy phenoxy halide" comment="" chebi-id="WO2007031823:155604" relevant="false" type="CLASS">ethoxy phenoxy halide</ne> and thereafter the deprotection to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.49" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne>. In all the examples given in this application, column chromatography has been used to purify <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.50" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> base before converting into <ne id="WO2007031823.HC.class-names.21" epochem-id="EPOCHEM:NEW:CLASS:952" name="hydrochloride salt" comment="" chebi-id="WO2007031823:710264" relevant="false" type="CLASS">hydrochloride salt</ne>.
</P>
<P>[0028]
EMI5.1
Alkali
EMI5.3
EMI5.2
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.51" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">TAMSULOSIN</ne>
Scheme III
In view of the above difficulties, the instant invention describes a new economical and industrially advantageous method to prepare <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.52" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> by using <ne id="WO2007031823.HC.class-names.17" epochem-id="EPOCHEM:NEW:CLASS:950" name="alkaline earth metal oxides" comment="" chebi-id="WO2007031823:259850" relevant="false" type="CLASS">alkaline earth metal oxides</ne> as <ne id="WO2007031823.HC.class-names.30" epochem-id="EPOCHEM:NEW:CLASS:1073" name="acid" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acid</ne> neutralizing agent in the alkylation reaction.
OBJECTIVE
The objective of the present invention is to provide an improved process for preparing highly pure <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.4" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> in high yield.
Yet another objective of the present invention is to provide a simple, industrially advantageous process to manufacture <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.5" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne>. SUMMARY OF THE INVENTION
The present invention relates to an improved process to prepare <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.6" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> of Formula I
Formula I
</P>
<P>[0038]
EMI6.1
which comprises
(i) reacting <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.22" epochem-id="EPOCHEM:NEW:COMPOUND:1782" name="(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" comment="R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:512503" relevant="false">(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide</ne> of Formula II
Formula II
EMI6.2
with substituted <ne type="LIGAND" id="WO2007031823.HC.ligand-names.61" epochem-id="EPOCHEM:NEW:LIGAND:539" name="phenoxy" comment="" chebi-id="WO2007031823:634678" relevant="false">phenoxy</ne> compound of Formula III,
Formula III
EMI6.3
wherein Z represents a removing group such as, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.1" epochem-id="EPOCHEM:NEW:LIGAND:486" name="OSO2CH3" comment="" chebi-id="WO2007031823:791843" relevant="false">OSO2CH3</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.3" epochem-id="EPOCHEM:NEW:LIGAND:487" name="OSO2C6H4CH3" comment="" chebi-id="WO2007031823:42042" relevant="false">OSO2C6H4CH3</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.5" epochem-id="EPOCHEM:NEW:LIGAND:488" name="F" comment="" chebi-id="CHEBI:29997,CHEBI:24061,CHEBI:17295" relevant="false">F</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.7" epochem-id="EPOCHEM:NEW:LIGAND:489" name="Br" comment="" chebi-id="CHEBI:47265" relevant="false">Br</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.9" epochem-id="EPOCHEM:NEW:LIGAND:490" name="Cl" comment="" chebi-id="CHEBI:23116" relevant="false">Cl</ne>, or -I, in a solvent in the presence of an <ne id="WO2007031823.HC.class-names.1" epochem-id="EPOCHEM:NEW:CLASS:641" name="alkaline earth metal oxide" comment="" chebi-id="WO2007031823:731285" relevant="false" type="CLASS">alkaline earth metal oxide</ne> to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.56" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> base and
(ii) converting <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.57" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> base into <ne id="WO2007031823.HC.class-names.22" epochem-id="EPOCHEM:NEW:CLASS:952" name="hydrochloride salt" comment="" chebi-id="WO2007031823:710264" relevant="false" type="CLASS">hydrochloride salt</ne> in a solvent by addition of aqueous <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.135" epochem-id="EPOCHEM:NEW:COMPOUND:395" name="hydrochloric acid" comment="" chebi-id="CHEBI:17883" relevant="false">hydrochloric acid</ne>. DETAILED DESCRIPTION OF THE INVENTION
Specifically, the present invention involves reacting compound of Formula II with compound of Formula III in presence of an <ne id="WO2007031823.HC.class-names.2" epochem-id="EPOCHEM:NEW:CLASS:641" name="alkaline earth metal oxide" comment="" chebi-id="WO2007031823:731285" relevant="false" type="CLASS">alkaline earth metal oxide</ne> selected from <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.74" epochem-id="EPOCHEM:COMPOUND:8340" name="calcium oxide" comment="" chebi-id="CHEBI:31344" relevant="false">calcium oxide</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.82" epochem-id="EPOCHEM:NEW:COMPOUND:1785" name="barium oxide" comment="" chebi-id="WO2007031823:504377" relevant="false">barium oxide</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.80" epochem-id="EPOCHEM:NEW:COMPOUND:1784" name="magnesium oxide" comment="" chebi-id="CHEBI:31794" relevant="false">magnesium oxide</ne> and the like. The said alkylation reaction is accomplished in presence of a solvent selected from C1-4 alcohol such as <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.85" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.103" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.111" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.116" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> and mixtures thereof, and preferably <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.117" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne>. Typically the alkylation reaction is completed by heating under reflux at 60-100[deg.]C and preferably at 80-90[deg.]C.
The major advantage realized in the present process is the use of <ne id="WO2007031823.HC.class-names.3" epochem-id="EPOCHEM:NEW:CLASS:641" name="alkaline earth metal oxide" comment="" chebi-id="WO2007031823:731285" relevant="false" type="CLASS">alkaline earth metal oxide</ne>, an <ne id="WO2007031823.HC.class-names.31" epochem-id="EPOCHEM:NEW:CLASS:1073" name="acid" comment="" chebi-id="CHEBI:37527" relevant="false" type="CLASS">acid</ne> neutralizing agent, to promote the alkylation reaction. <ne id="WO2007031823.HC.class-names.18" epochem-id="EPOCHEM:NEW:CLASS:951" name="Alkaline earth metal salts" comment="" chebi-id="WO2007031823:47688" relevant="false" type="CLASS">Alkaline earth metal salts</ne> are insoluble in the reaction medium and are removed easily by filtration after the alkylation reaction is over.
In yet another embodiment of the present invention, the solvent employed during formation of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.7" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> and during its purification is selected from <ne id="WO2007031823.HC.class-names.34" epochem-id="EPOCHEM:NEW:CLASS:1154" name="Ci-4 alcohol" comment="C1-4 alcohol" chebi-id="WO2007031823:794759" relevant="false" type="CLASS">Ci-4 alcohol</ne> such as <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.86" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.104" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.112" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.118" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> and mixtures thereof, and preferably <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.87" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne>.
The invention is illustrated with the following examples, which are provided by way of illustration only and should not be construed to limit the scope of the invention.
EXAMPLE 1
Step (i):
PREPARATION OF CRUDE <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.8" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne> A mixture of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.23" epochem-id="EPOCHEM:NEW:COMPOUND:1782" name="(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" comment="R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:512503" relevant="false">(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide</ne> (20 g, 0.082 mol), <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.133" epochem-id="EPOCHEM:NEW:COMPOUND:1789" name="2-(2-ethoxyphenoxy)ethyl methanesulfonate" comment="" chebi-id="WO2007031823:86632" relevant="true">2-(2-ethoxyphenoxy)ethyl methanesulfonate</ne> (19.18 g, 0.074 mol), <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.75" epochem-id="EPOCHEM:COMPOUND:8340" name="calcium oxide" comment="" chebi-id="CHEBI:31344" relevant="false">calcium oxide</ne> (4.6 g, 0.821 mol) and <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.119" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> (300 ml) was heated at 80- 85[deg.]C for 25 h. The reaction mass was filtered to remove calcium salts and the residue was washed with hot <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.120" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> (2x10 ml, 70[deg.]C). Thereafter, pH of the filtrate was adjusted to 1.0 using <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.136" epochem-id="EPOCHEM:NEW:COMPOUND:395" name="hydrochloric acid" comment="" chebi-id="CHEBI:17883" relevant="false">hydrochloric acid</ne> (10 g) at 60-65[deg.]C and the resulting product slurry was allowed to cool to 0-5[deg.]C. The solid thus obtained was filtered, washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.121" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> (2x10 ml, 5[deg.]C). Yield: 43 g (wet).
Step (ii): PREPARATION OF PURE <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.9" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne>
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.129" epochem-id="EPOCHEM:NEW:COMPOUND:1787" name="(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride" comment="R-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride" chebi-id="WO2007031823:949570" relevant="false">(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy) ethyl] amino] propyl]-2- methoxybenzenesulfonamide hydrochloride</ne> (43 g, wet) was suspended in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.88" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (140 ml) and stirred at 55-60&lt;0&gt;C for 30 min. This suspension was cooled to 0-5&lt;0&gt;C, filtered and washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.89" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (10 ml, 0&lt;0&gt;C). The filtered product (23 g) was dissolved in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.90" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (400 ml) at 55-60&lt;0&gt;C and treated with <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.189" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> (0.6 g) at the same temperature. <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.190" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">Carbon</ne> was removed through hyflo and the residue was washed with hot <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.91" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (2x25 ml, 60&lt;0&gt;C). The filtrate was concentrated under vacuum to a volume of about 150 ml. The product slurry was cooled and stirred at 0- 5[deg.]C for 2 h. The mass was filtered, washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.92" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (10 ml, 0&lt;0&gt;C) and dried to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.10" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne>. Yield: 19 g. Chromatographic Purity: 99.76% (HPLC).
EXAMPLE 2
Step (i):
PREPARATION OF CRUDE <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.11" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne>
A mixture of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.132" epochem-id="EPOCHEM:NEW:COMPOUND:1788" name="(i?)-(-)-5-(2-aminopropyi)-2-methoxybenzenesulfonamide" comment="R-(-)-5-(2-aminopropyi)-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:769757" relevant="true">(i?)-(-)-5-(2-aminopropyi)-2-methoxybenzenesulfonamide</ne> (3 g, 0.0123 mol), <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.134" epochem-id="EPOCHEM:NEW:COMPOUND:1789" name="2-(2-ethoxyphenoxy)ethyl methanesulfonate" comment="" chebi-id="WO2007031823:86632" relevant="true">2-(2-ethoxyphenoxy)ethyl methanesulfonate</ne> (2.88 g, 0.011 mol), <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.76" epochem-id="EPOCHEM:COMPOUND:8340" name="calcium oxide" comment="" chebi-id="CHEBI:31344" relevant="false">calcium oxide</ne> (0.52 g, 0.0093 mol) and <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.105" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne> (60 ml) was heated at 78-8O&lt;0&gt;C for 35 h. The reaction mass was filtered and the residue was washed with hot <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.106" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne> (4 ml, 70&lt;0&gt;C). The pH of filtrate was adjusted to 1.0 using <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.137" epochem-id="EPOCHEM:NEW:COMPOUND:395" name="hydrochloric acid" comment="" chebi-id="CHEBI:17883" relevant="false">hydrochloric acid</ne> (1.68 g) at 60-65[deg.]C and the resulting product slurry was allowed to cool to 0-5[deg.]C. The solid thus obtained was filtered, washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.107" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne> (4 ml, 5&lt;0&gt;C). Yield: 6 g (wet)
Step (ii):
PREPARATION OF PURE <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.12" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne>
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.130" epochem-id="EPOCHEM:NEW:COMPOUND:1787" name="(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride" comment="R-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride" chebi-id="WO2007031823:949570" relevant="false">(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl] amino] propyl]-2- methoxybenzenesulfonamide hydrochloride</ne> (6 g, wet) was suspended in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.93" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (21 ml) and stirred at 55-6O&lt;0&gt;C for 30 min. The suspension was cooled to 0-5&lt;0&gt;C, filtered and washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.94" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (4 ml, 0&lt;0&gt;C). The filtered product (3.1 g) was dissolved in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.95" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (60 ml) at 55-6O&lt;0&gt;C and treated with <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.191" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> (0.1 g) for 15 min. <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.192" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">Carbon</ne> was removed by filtration and the filtrate was concentrated under vacuum to a volume of about 25 ml. The slurry was cooled and stirred at 0-5&lt;0&gt;C for 2 h. The product was filtered, washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.96" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (4 ml, 0&lt;0&gt;C) and dried to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.13" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne>. Yield: 2.65 g. Chromatographic Purity: 99.70% (HPLC).
EXAMPLE 3
Step (i): PREPARATION OF CRUDE <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.14" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne>
A mixture of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.24" epochem-id="EPOCHEM:NEW:COMPOUND:1782" name="(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" comment="R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:512503" relevant="false">(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide</ne> (3 g, 0.0123 mol), 2-(2-ethoxyphenoxy)ethyl bromide (3.05 g, 0.0124 mol), <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.77" epochem-id="EPOCHEM:COMPOUND:8340" name="calcium oxide" comment="" chebi-id="CHEBI:31344" relevant="false">calcium oxide</ne> (0.52 g, 0.0093 mol) and <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.122" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> (45 ml) was heated at 80-90&lt;0&gt;C for 22 h. The reaction mass was filtered and the residue was washed with hot <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.123" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> (4 ml, 70&lt;0&gt;C). The pH of filtrate was adjusted to 1.0 with <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.138" epochem-id="EPOCHEM:NEW:COMPOUND:395" name="hydrochloric acid" comment="" chebi-id="CHEBI:17883" relevant="false">hydrochloric acid</ne> at 60-65&lt;0&gt;C and the contents were cooled to 0-5[deg.]C. The solid thus obtained was filtered, washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.124" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> (4 ml, 5[deg.]C). Yield: 7.5 g (wet)
Step (ii): PREPARATION OF PURE <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.15" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">TAMSULOSIN HYDROCHLORIDE</ne>
<ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.131" epochem-id="EPOCHEM:NEW:COMPOUND:1787" name="(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride" comment="R-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride" chebi-id="WO2007031823:949570" relevant="false">(i?)-(-)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride</ne> (7.5 g) was suspended in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.97" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (20 ml) and stirred at 55-60[deg.]C for 30 min. The suspension was cooled to 0-5[deg.]C and filtered. The product (3.5 g), thus obtained, was dissolved in <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.98" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (60 ml) at 55-6O&lt;0&gt;C and treated with <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.193" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> (0.1 g). Thereafter, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.194" epochem-id="EPOCHEM:COMPOUND:6728" name="carbon" comment="" chebi-id="CHEBI:27594" relevant="false">carbon</ne> was removed through hyflo and the filtrate was concentrated to a volume of about 25 ml under vacuum. The product slurry was cooled to 0-5&lt;0&gt;C. The product was collected by filtration, washed with precooled <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.99" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne> (4 ml, 0&lt;0&gt;C) and dried to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.16" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne>. Yield: 2.45 g. Chromatographic Purity: 99.89% (HPLC).
WE CLAIM
</P>
<P>1. An improved process to prepare <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.17" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> of Formula I
Formula I
EMI11.1
which comprises
(i) reacting <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.25" epochem-id="EPOCHEM:NEW:COMPOUND:1782" name="(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" comment="R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide" chebi-id="WO2007031823:512503" relevant="false">(i?)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide</ne> of Formula II
Formula II
EMI11.2
with substituted <ne type="LIGAND" id="WO2007031823.HC.ligand-names.62" epochem-id="EPOCHEM:NEW:LIGAND:539" name="phenoxy" comment="" chebi-id="WO2007031823:634678" relevant="false">phenoxy</ne> compound of Formula III,
Formula III
EMI11.3
wherein Z represents a removing group such as, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.2" epochem-id="EPOCHEM:NEW:LIGAND:486" name="OSO2CH3" comment="" chebi-id="WO2007031823:791843" relevant="false">OSO2CH3</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.4" epochem-id="EPOCHEM:NEW:LIGAND:487" name="OSO2C6H4CH3" comment="" chebi-id="WO2007031823:42042" relevant="false">OSO2C6H4CH3</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.6" epochem-id="EPOCHEM:NEW:LIGAND:488" name="F" comment="" chebi-id="CHEBI:29997,CHEBI:24061,CHEBI:17295" relevant="false">F</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.8" epochem-id="EPOCHEM:NEW:LIGAND:489" name="Br" comment="" chebi-id="CHEBI:47265" relevant="false">Br</ne>, -<ne type="LIGAND" id="WO2007031823.HC.ligand-names.10" epochem-id="EPOCHEM:NEW:LIGAND:490" name="Cl" comment="" chebi-id="CHEBI:23116" relevant="false">Cl</ne>, or -I, in a solvent in the presence of an <ne id="WO2007031823.HC.class-names.4" epochem-id="EPOCHEM:NEW:CLASS:641" name="alkaline earth metal oxide" comment="" chebi-id="WO2007031823:731285" relevant="false" type="CLASS">alkaline earth metal oxide</ne> to obtain <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.69" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> base and
(ii) converting <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.70" epochem-id="EPOCHEM:NEW:COMPOUND:1783" name="Tamsulosin" comment="" chebi-id="CHEBI:9398" relevant="true">Tamsulosin</ne> base into <ne id="WO2007031823.HC.class-names.23" epochem-id="EPOCHEM:NEW:CLASS:952" name="hydrochloride salt" comment="" chebi-id="WO2007031823:710264" relevant="false" type="CLASS">hydrochloride salt</ne> in a solvent by addition of aqueous <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.139" epochem-id="EPOCHEM:NEW:COMPOUND:395" name="hydrochloric acid" comment="" chebi-id="CHEBI:17883" relevant="false">hydrochloric acid</ne>.
</P>
<P>2. The process according to claim 1 wherein the alkaline earth metal salt is <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.78" epochem-id="EPOCHEM:COMPOUND:8340" name="calcium oxide" comment="" chebi-id="CHEBI:31344" relevant="false">calcium oxide</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.81" epochem-id="EPOCHEM:NEW:COMPOUND:1784" name="magnesium oxide" comment="" chebi-id="CHEBI:31794" relevant="false">magnesium oxide</ne> and <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.83" epochem-id="EPOCHEM:NEW:COMPOUND:1785" name="barium oxide" comment="" chebi-id="WO2007031823:504377" relevant="false">barium oxide</ne>.
</P>
<P>3. The process according to claim 1 wherein the solvent used in step (i) is selected from <ne id="WO2007031823.HC.class-names.35" epochem-id="EPOCHEM:NEW:CLASS:1154" name="Ci-4 alcohol" comment="C1-4 alcohol" chebi-id="WO2007031823:794759" relevant="false" type="CLASS">Ci-4 alcohol</ne> such as <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.100" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.108" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.113" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.125" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> and mixtures thereof.
</P>
<P>4. The process according to claim 3 wherein the solvent is <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.126" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne>.
</P>
<P>5. The process according to claim 1 wherein the reaction of compound of Formula II with a compound of Formula III is carried out at 80-90&lt;0&gt;C.
</P>
<P>6. The process according to claim 1 wherein the solvent used in step (ii) is selected from <ne id="WO2007031823.HC.class-names.36" epochem-id="EPOCHEM:NEW:CLASS:1154" name="Ci-4 alcohol" comment="C1-4 alcohol" chebi-id="WO2007031823:794759" relevant="false" type="CLASS">Ci-4 alcohol</ne>, such as <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.101" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.109" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.114" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.127" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> and mixtures thereof.
</P>
<P>7. The process according to claim 1 to 5 wherein <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.18" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> is further purified by dissolving in a solvent selected from <ne id="WO2007031823.HC.class-names.37" epochem-id="EPOCHEM:NEW:CLASS:1154" name="Ci-4 alcohol" comment="C1-4 alcohol" chebi-id="WO2007031823:794759" relevant="false" type="CLASS">Ci-4 alcohol</ne>, such as <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.102" epochem-id="EPOCHEM:COMPOUND:4792" name="methanol" comment="" chebi-id="CHEBI:17790" relevant="false">methanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.110" epochem-id="EPOCHEM:COMPOUND:4765" name="ethanol" comment="" chebi-id="CHEBI:16236" relevant="false">ethanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.115" epochem-id="EPOCHEM:NEW:COMPOUND:97" name="isopropanol" comment="" chebi-id="CHEBI:17824" relevant="false">isopropanol</ne>, <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.128" epochem-id="EPOCHEM:NEW:COMPOUND:1786" name="isobutyl alcohol" comment="" chebi-id="CHEBI:46645" relevant="false">isobutyl alcohol</ne> and mixtures thereof, and precipitating the pure <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.19" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne>.
</P>
<P>8. An improved process for the preparation of <ne type="CHEMICAL" id="WO2007031823.HC.chemical-names.20" epochem-id="EPOCHEM:NEW:COMPOUND:1781" name="Tamsulosin hydrochloride" comment="" chebi-id="CHEBI:9399" relevant="true">Tamsulosin hydrochloride</ne> of Formula I, as defined in claim 1, substantially as herein described with reference to the examples.
</P></DIV>
<DIV><P>
</P></DIV>
</BODY>
</PAPER>
